Does NEOMYCIN Cause Mobility decreased? 392 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 392 reports of Mobility decreased have been filed in association with NEOMYCIN (Antibiotic and Pain Relief). This represents 25.9% of all adverse event reports for NEOMYCIN.
392
Reports of Mobility decreased with NEOMYCIN
25.9%
of all NEOMYCIN reports
387
Deaths
352
Hospitalizations
How Dangerous Is Mobility decreased From NEOMYCIN?
Of the 392 reports, 387 (98.7%) resulted in death, 352 (89.8%) required hospitalization, and 333 (84.9%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEOMYCIN. However, 392 reports have been filed with the FAERS database.
What Other Side Effects Does NEOMYCIN Cause?
Drug hypersensitivity (582)
Infusion related reaction (560)
Drug ineffective (541)
Type 2 diabetes mellitus (517)
Swelling (491)
Pyrexia (484)
Rash (484)
Systemic lupus erythematosus (483)
Rheumatoid arthritis (478)
Off label use (471)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which NEOMYCIN Alternatives Have Lower Mobility decreased Risk?
NEOMYCIN vs NEORAL
NEOMYCIN vs NEOSTIGMINE
NEOMYCIN vs NEOSTIGMINE METHYLSULFATE
NEOMYCIN vs NEPAFENAC
NEOMYCIN vs NERATINIB